| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |